Historical shareholding details of iShares Micro-Cap ETF holdings in BioXcel Therapeutics Inc (BTAI)

Monthly changes of iShares Micro-Cap ETF shareholding in BioXcel Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Micro-Cap Etf 5,092 0.16%
Feb 27, 2025 Ishares Micro-Cap Etf 5,092 0.16%
Feb 26, 2025 Ishares Micro-Cap Etf 5,092 0.16%
Jan 31, 2025 Ishares Micro-Cap Etf 84,291 0.17%
Jan 29, 2025 Ishares Micro-Cap Etf 84,291 0.17%
Dec 31, 2024 Ishares Micro-Cap Etf 83,159 0.17%
Dec 30, 2024 Ishares Micro-Cap Etf 83,159 0.17%
Nov 30, 2024 Ishares Micro-Cap Etf 82,027 0.17%
Nov 27, 2024 Ishares Micro-Cap Etf 82,027 0.17%
Oct 31, 2024 Ishares Micro-Cap Etf 82,027 0.19%
Oct 30, 2024 Ishares Micro-Cap Etf 82,027 0.20%
Oct 29, 2024 Ishares Micro-Cap Etf 78,316 0.19%
Sep 30, 2024 Ishares Micro-Cap Etf 65,037 0.16%
Sep 27, 2024 Ishares Micro-Cap Etf 65,037 0.16%
Sep 25, 2024 Ishares Micro-Cap Etf 65,037 0.16%
Aug 30, 2024 Ishares Micro-Cap Etf 65,482 0.16%
Aug 29, 2024 Ishares Micro-Cap Etf 65,482 0.16%
Aug 28, 2024 Ishares Micro-Cap Etf 65,482 0.16%
Jul 31, 2024 Ishares Micro-Cap Etf 64,592 0.16%
Jul 29, 2024 Ishares Micro-Cap Etf 64,592 0.17%
Jun 28, 2024 Ishares Micro-Cap Etf 62,367 0.17%
Jun 13, 2024 Ishares Micro-Cap Etf 42,746 0.12%
May 30, 2024 - - 0.12%
May 29, 2024 Ishares Micro-Cap Etf 44,261 0.12%
Apr 26, 2024 Ishares Micro-Cap Etf 45,170 0.15%
Mar 28, 2024 Ishares Micro-Cap Etf 46,079 0.15%
Mar 26, 2024 Ishares Micro-Cap Etf 46,079 0.15%
Feb 29, 2024 Ishares Micro-Cap Etf 46,685 0.15%
Feb 28, 2024 Ishares Micro-Cap Etf 46,685 0.15%
Jan 29, 2024 Ishares Micro-Cap Etf 44,686 0.15%
Dec 27, 2023 Ishares Micro-Cap Etf 44,686 0.15%
Nov 29, 2023 Ishares Micro-Cap Etf 44,400 0.15%
Oct 30, 2023 Ishares Micro-Cap Etf 44,114 0.15%
Sep 27, 2023 Ishares Micro-Cap Etf 45,258 0.15%
Aug 29, 2023 Ishares Micro-Cap Etf 43,112 0.15%
Jul 28, 2023 Ishares Micro-Cap Etf 43,654 0.15%
Jun 21, 2023 Ishares Micro-Cap Etf 41,417 0.14%
May 30, 2023 Ishares Micro-Cap Etf 41,083 0.14%

View all ownership details of BioXcel Therapeutics Inc